Editas Medicine Inc (EDIT)
5.36
-0.10
(-1.83%)
USD |
NASDAQ |
Apr 24, 16:00
5.36
0.00 (0.00%)
After-Hours: 18:38
Editas Medicine Price: 5.36 for April 24, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 23, 2024 | 5.66 | 5.92 | 5.46 | 5.46 | 1.401M |
| Apr 22, 2024 | 5.59 | 5.79 | 5.38 | 5.60 | 1.745M |
| Apr 19, 2024 | 5.52 | 5.68 | 5.285 | 5.49 | 2.265M |
| Apr 18, 2024 | 5.60 | 5.68 | 5.511 | 5.55 | 1.716M |
| Apr 17, 2024 | 5.89 | 5.93 | 5.60 | 5.61 | 1.910M |
| Apr 16, 2024 | 5.98 | 6.03 | 5.85 | 5.85 | 1.339M |
| Apr 15, 2024 | 6.25 | 6.29 | 5.975 | 6.08 | 1.772M |
| Apr 12, 2024 | 6.53 | 6.53 | 6.13 | 6.21 | 2.025M |
| Apr 11, 2024 | 6.65 | 6.767 | 6.44 | 6.58 | 1.476M |
| Apr 10, 2024 | 6.80 | 6.80 | 6.54 | 6.63 | 2.135M |
| Apr 09, 2024 | 6.74 | 7.03 | 6.665 | 7.01 | 1.569M |
| Apr 08, 2024 | 6.74 | 6.87 | 6.68 | 6.72 | 1.040M |
| Apr 05, 2024 | 6.77 | 6.845 | 6.62 | 6.72 | 1.255M |
| Apr 04, 2024 | 7.00 | 7.09 | 6.77 | 6.81 | 2.095M |
| Apr 03, 2024 | 6.82 | 7.025 | 6.654 | 6.86 | 1.813M |
| Apr 02, 2024 | 7.12 | 7.13 | 6.86 | 6.87 | 2.221M |
| Apr 01, 2024 | 7.41 | 7.41 | 7.145 | 7.28 | 1.247M |
| Mar 28, 2024 | 7.46 | 7.52 | 7.365 | 7.42 | 1.561M |
| Mar 27, 2024 | 7.31 | 7.53 | 7.185 | 7.44 | 1.282M |
| Mar 26, 2024 | 7.46 | 7.585 | 7.20 | 7.22 | 1.851M |
| Mar 25, 2024 | 7.46 | 7.595 | 7.32 | 7.36 | 1.171M |
| Mar 22, 2024 | 7.76 | 7.775 | 7.44 | 7.47 | 1.268M |
| Mar 21, 2024 | 8.00 | 8.44 | 7.81 | 7.83 | 1.986M |
| Mar 20, 2024 | 7.67 | 8.12 | 7.59 | 7.92 | 2.354M |
| Mar 19, 2024 | 7.68 | 7.98 | 7.60 | 7.75 | 1.994M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
5.36
Minimum
Apr 24 2024
90.58
Maximum
Jan 08 2021
23.95
Average
21.67
Median
Price Benchmarks
| Vertex Pharmaceuticals Inc | 400.73 |
| Moderna Inc | 108.86 |
| Amicus Therapeutics Inc | 10.52 |
| Geron Corp | 3.57 |
| Regeneron Pharmaceuticals Inc | 906.80 |
Price Related Metrics
| PS Ratio | 5.210 |
| Price to Book Value | 1.256 |
| Earnings Yield | -38.25% |
| Market Cap | 438.52M |